Oral solid dosage form using alternate crystalline neratinib maleate anhydrous form: Pharmaceutical, bioequivalent, and clinical perspectives.

Ming C, Liu Z, Wang Q, Liu L, Shen X

Open source

DOI
10.1002/bmc.5988
Published
2024 Nov
Container
Biomedical chromatography : BMC
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/bmc.5988,
  title = {Oral solid dosage form using alternate crystalline neratinib maleate anhydrous form: Pharmaceutical, bioequivalent, and clinical perspectives.},
  author = {Ming C and Liu Z and Wang Q and Liu L and Shen X},
  year = {2024},
  journal = {Biomedical chromatography : BMC},
  doi = {10.1002/bmc.5988},
  url = {https://doi.org/10.1002/bmc.5988}
}

RIS

TY  - JOUR
TI  - Oral solid dosage form using alternate crystalline neratinib maleate anhydrous form: Pharmaceutical, bioequivalent, and clinical perspectives.
AU  - Ming C
AU  - Liu Z
AU  - Wang Q
AU  - Liu L
AU  - Shen X
PY  - 2024
JO  - Biomedical chromatography : BMC
DO  - 10.1002/bmc.5988
UR  - https://doi.org/10.1002/bmc.5988
ER  - 

APA

C, M., Z, L., Q, W., L, L., & X, S. (2024). Oral solid dosage form using alternate crystalline neratinib maleate anhydrous form: Pharmaceutical, bioequivalent, and clinical perspectives.. Biomedical chromatography : BMC. https://doi.org/10.1002/bmc.5988

Source records